Skip to Main content Skip to Navigation
Journal articles

2018 Consensus of the French Society of Endocrinology: endocrine toxicities of cancer immunotherapies

Frederic Costinetti Francoise Borson-Chazot 1 Frederique Aibarel Francoise Archambeaud 2 Jerome Bertherat 3 Benjamin Bouillet 4, 5 Perrine Buffier 4 Claire Briet 6 Bertrand Cariou 7, 8, 9 Philippe Caron Olivier Chabre 10 Philippe Chanson 11, 12 Christine Cortet 13 Christine Do Cao 13 Delphine Drui 14 Magali Haissaguerre 15 Segolene Hescot 16 Frederic Illouz 17 Emmanuelle Kuhn 12 Najiba Lahlou 18 Emilie Merlen 13 Veronique Raverot 19 Sarra Smati 20 Bruno Verges 21, 4 Consensus Sfe 2018 
Abstract : Immunotherapy induced side effects: Are frequent, usually well-tolerated, and can lead to thyroid, pituitary, and less frequently adrenals and pancreas (fulminant diabetes) disease,. Do not contra-indicate immunotherapy, and rarely require high dose glucocorticoids; Need to be screened for, as there are acute manifestations, and replacement treatments can be given lifelong; Require a pre-immunotherapy evaluation; Require a careful follow-up at least during the first 6 months of immunotherapy.
Document type :
Journal articles
Complete list of metadata
Contributor : Valérie Gall Connect in order to contact the contributor
Submitted on : Thursday, January 30, 2020 - 4:36:12 PM
Last modification on : Monday, July 4, 2022 - 10:19:50 AM


  • HAL Id : hal-02461465, version 1


Frederic Costinetti, Francoise Borson-Chazot, Frederique Aibarel, Francoise Archambeaud, Jerome Bertherat, et al.. 2018 Consensus of the French Society of Endocrinology: endocrine toxicities of cancer immunotherapies. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2019, 23 (2), pp.31-36. ⟨hal-02461465⟩



Record views